20 The PIONEER 6 trial (Oral Semaglutide and Cardiovascular Outcomes in Patients With Type 2 Diabetes) 21 found that the incidence of major adverse cardiovascular events was 21% lower with oral semaglutide than with placebo, but the difference was not statistically significant ( P = .17)
Maximum concentration: 144,802 mg of L-Carnitine per kilo
Therefore, for those with obesity-related asthma, semaglutide could be promising as it addresses weight issues and may lead to better asthma management
As this research shifts the discussion from simple volume loss toward preservation and regeneration of skin quality, regenerative treatments like Sculptra, PRF (Platelet-Rich Fibrin), microneedling, and the use of energy-based collagen stimulation decides may become increasingly popular for GLP-1 patients
Although this risk hasnt been confirmed in humans, its considered a serious precaution